CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,220 | $565.36 | $1.8M | 42,483 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,950 | $566.70 | $1.1M | 40,533 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −20 | $567.41 | $11K | 40,513 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 119,788 | ||
| 2026-04-24 | PATUSKY CHRISTOPHER Director | Option exercise 10b5-1 | +2,910 | $101.80 | $296K | 4,400 |
| 2026-04-24 | PATUSKY CHRISTOPHER Director | Sale 10b5-1 | −2,910 | $569.00 | $1.7M | 1,490 |
| 2026-04-24 | PATUSKY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −2,910 | 0 | ||
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −280 | $569.63 | $159K | 28,596 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,079 | $570.82 | $616K | 27,517 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,325 | $571.64 | $1.9M | 24,192 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,976 | $572.66 | $2.3M | 20,216 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −321 | $573.51 | $184K | 19,895 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −535 | $574.79 | $308K | 19,360 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $576.62 | $69K | 18,876 |
| 2026-04-23 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 62,500 | ||
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −245 | $569.62 | $140K | 49,768 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,055 | $570.76 | $602K | 48,713 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,921 | $571.59 | $1.7M | 45,792 |
Page 117 of 121 · 2,404 trades